9 Meters Biopharma, Inc.
NMTRQ
$0.00
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -81.37% | -73.09% | -70.41% | -53.99% | -3.26% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.73% | 12.27% | -9.67% | 12.36% | 30.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -76.47% | -33.94% | -67.33% | -52.35% | -2.24% |
|
|
|||||
| Total Current Assets | -76.47% | -33.94% | -67.33% | -52.35% | -2.24% |
| Net Property, Plant & Equipment | -37.54% | -32.84% | -28.68% | -24.93% | -21.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 60.71% | 30.36% | 420,296.43% | 0.00% | 0.00% |
| Total Assets | -76.28% | -33.93% | -25.66% | -52.26% | -2.35% |
|
|
|||||
| Total Accounts Payable | 121.31% | 107.56% | 9.21% | 42.21% | 39.48% |
| Total Accrued Expenses | -7.96% | -26.61% | 14.59% | 38.34% | 37.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.57% | 35,808.94% | 4,986.28% | 12.79% | 12.77% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 89.41% | 262.96% | 76.66% | 39.08% | 37.37% |
|
|
|||||
| Total Current Liabilities | 89.41% | 262.96% | 76.66% | 39.08% | 37.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -64.63% | -54.55% | -47.06% | -41.16% | -36.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 87.59% | 258.77% | 287.05% | 37.43% | 35.51% |
|
|
|||||
| Common Stock & APIC | 4.28% | 2.17% | 2.68% | 4.16% | 23.07% |
| Retained Earnings | -25.69% | -25.92% | -25.99% | -31.27% | -31.06% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -120.36% | -94.23% | -72.68% | -62.65% | -9.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -120.36% | -94.23% | -72.68% | -62.65% | -9.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -120.36% | -94.23% | -72.68% | -62.65% | -9.17% |
|
|
|||||
